Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicensePlus Black IconRevocationPlus Black IconReissuePlus Black IconCorrected translationPlus Black IconSPC

EP3518930

Samsett meðferð með hæglosandi CNP örvum

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    28.9.2017
  • EP published:
    8.3.2023
  • EP application number:
    17781429.0
  • Max expiry date:
    27.9.2037
  • Expiry date:
    27.9.2026
  • Next due date:
    30.9.2026
  • Title in English:
    COMBINATION THERAPY WITH CONTROLLED-RELEASE CNP AGONISTS
  • Language of the patent:
    English

Timeline

Today
28.9.2017EP application
8.3.2023EP Publication
17.4.2023Translation submitted
15.5.2023Registration published
27.9.2026Expires

Owner

  • Name:
    Ascendis Pharma Growth Disorders A/S
  • Address:
    Tuborg Boulevard 12, 2900 Hellerup, DK

Inventor

  • Name:
    HOLTEN-ANDERSEN, Lars
  • Address:
    2900 Hellerup, DK
  • Name:
    MILLER BREINHOLT, Vibeke
  • Address:
    2900 Hellerup, DK
  • Name:
    SPROGØE, Kennett
  • Address:
    2900 Hellerup, DK

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    16191456
  • Date:
    29.9.2016
  • Country:
    EP

Classification

  • Categories:
    A61K 47/60, A61K 31/505, A61K 38/22, A61K 38/27, A61P 19/08

Annual fees

Number

Paid

Expires

Payer

Number: 7

Paid: 25.9.2023

Expires: 27.9.2024

Payer: Árnason Faktor ehf.

Number: 8

Paid: 17.9.2024

Expires: 27.9.2025

Payer: Árnason Faktor ehf.

Number: 9

Paid: 24.9.2025

Expires: 27.9.2026

Payer: Árnason Faktor ehf.

Upload documents